how glp 1 meds work Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 Therapy Part 1: Setting

That said, these effects are not yet well established clinically, and more research is needed to determine whether they are directly caused by the medication or influenced by factors such as weight loss, metabolic changes, or individual physiology

Accordingly, recent systematic reviews have provided substantial reassurance regarding the psychiatric safety profile of GLP-1RAs

Some markets that I think lend themselves to this dynamic are drugs for addiction, innovations in organ transplantation, drug + device combinations, psychedelic therapies, sarcopenia, frailty, or drugs for aging that appears to be a growing category

The higher 7.2 mg dose (Wegovy HD) led to about 18.7% weight loss at 72 weeks